Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial

Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:26:10.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a pilot study involving pembrolizumab, exemestane, and leuprolide for premenopausal hormone receptor positive/HER2 negative breast cancer patients resistant to front-line hormonal therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:19:16.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as being a female adult over 20 years old with histologically confirmed ER and/or PR positive breast cancer, among other conditions. Previously, this section had no information provided.
    Difference
    40%
    Check dated 2024-05-22T19:40:45.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention possibly related to medical and healthcare publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T21:55:27.000Z thumbnail image

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.